ConvaTec Group (LON:CTEC) Receives Outperform Rating from Royal Bank Of Canada

ConvaTec Group (LON:CTEC)‘s stock had its “outperform” rating reissued by research analysts at Royal Bank Of Canada in a research note issued on Monday,London Stock Exchange reports. They currently have a GBX 315 target price on the stock. Royal Bank Of Canada’s price objective points to a potential upside of 37.80% from the stock’s previous close.

CTEC has been the topic of a number of other reports. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a GBX 315 price target on shares of ConvaTec Group in a research note on Wednesday, April 8th. JPMorgan Chase & Co. cut their price objective on ConvaTec Group from GBX 307 to GBX 294 and set an “overweight” rating on the stock in a report on Friday, May 22nd. UBS Group reissued a “buy” rating and set a GBX 375 target price on shares of ConvaTec Group in a research note on Monday, May 18th. Berenberg Bank restated a “buy” rating and set a GBX 340 target price on shares of ConvaTec Group in a report on Tuesday, April 21st. Finally, Jefferies Financial Group restated a “buy” rating and set a GBX 300 target price on shares of ConvaTec Group in a report on Monday, June 8th. Eight research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat, ConvaTec Group has a consensus rating of “Moderate Buy” and an average price target of GBX 306.

ConvaTec Group Stock Up 2.1%

ConvaTec Group stock opened at GBX 228.60 on Monday. ConvaTec Group has a fifty-two week low of GBX 193 and a fifty-two week high of GBX 259.30. The company has a debt-to-equity ratio of 99.96, a quick ratio of 0.96 and a current ratio of 1.53. The firm has a 50 day moving average price of GBX 210.63 and a 200 day moving average price of GBX 221.20. The company has a market capitalization of £4.47 billion, a PE ratio of 26.58, a price-to-earnings-growth ratio of 0.93 and a beta of 0.76.

Insiders Place Their Bets

In related news, insider Jonny Mason purchased 50,000 shares of the business’s stock in a transaction on Tuesday, May 26th. The shares were bought at an average price of GBX 201 per share, for a total transaction of £100,500. 0.98% of the stock is currently owned by company insiders.

ConvaTec Group Company Profile

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer.